妊娠期甲状腺功能检查异常的风险因素:一项系统综述以验证现有风险因素并识别新风险因素
该研究系统检索Embase、Medline Ovid和Cochrane Library(截至2024年10月17日),纳入81篇文章、36个候选变量,发现甲状腺抗体阳性者显性或亚临床甲状腺功能减退症风险高于抗体阴性者,碘摄入状态与亚临床甲状腺功能减退症风险相关,现有大多数推荐风险因素的证据有限且异质,未识别出新风险因素。
要点
- 甲状腺抗体阳性者显性甲减绝对风险2.4-7.0%,抗体阴性者0.1-0.2%。
- 甲状腺抗体阳性者亚临床甲减绝对风险1.9-29.0%,抗体阴性者2.0-5.7%。
- 碘缺乏、充足、超妊娠需求或过量时亚临床甲减绝对风险分别为2.2-42.6%、1.42-16.0%、3.8-24.3%。
核心结论
- 现有大多数推荐风险因素的证据仍然有限且异质,未识别出新风险因素;风险因素可帮助指导妊娠期甲状腺功能检查,但临床风险评估不可替代;未来需研究识别新风险因素以提高识别高危孕妇的准确性和效率,尤其是显性甲减。
研究设计与样本
- 系统综述,检索Embase、Medline Ovid和Cochrane Library从建库至2024年10月17日,纳入81篇文章,描述36个候选变量,使用纽卡斯尔-渥太华量表评估研究质量,采用叙述性综合总结结果。
主要发现
- 甲状腺抗体阳性者发生显性甲减的绝对风险为2.4-7.0%,抗体阴性者为0.1-0.2%;发生亚临床甲减的绝对风险为1.9-29.0%,抗体阴性者为2.0-5.7%。
- 碘缺乏、充足、摄入超妊娠需求或过量时,亚临床甲减的绝对风险分别为2.2-42.6%、1.42-16.0%、3.8-24.3%。
- 关于自身免疫性疾病史、甲状腺疾病家族史、甲减症状、妊娠丢失史、早产或不孕史的研究数量有限。
- 现有风险因素与孤立性低甲状腺素血症或(亚临床)甲状腺功能亢进症关联很小或没有关联。
- 未识别出甲状腺功能检查异常的新风险因素。
临床怎么用
- 风险因素可帮助指导妊娠期甲状腺功能检查,但临床风险评估不可替代。
局限性
- 现有大多数推荐风险因素的证据仍然有限且异质。
- 未来需要研究识别新风险因素,以提高识别甲状腺功能检查异常(尤其是显性甲减)高危孕妇的准确性和效率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: International guidelines recommend that the indication to perform thyroid function testing during pregnancy is based on the presence of risk factors for thyroid function test abnormalities. However, the discriminative ability of currently recommended risk factors is questionable. To inform on an update of the American Thyroid Association Guidelines for the Diagnosis and Management of Thyroid Disease in Preconception, Pregnancy, and the Postpartum, we aimed to systematically review the literature to evaluate evidence for current risk factors and potential novel ones for thyroid function test abnormalities in pregnancy. Methods: A systematic literature search was performed on Embase, Medline Ovid, and the Cochrane Library from inception to October 17, 2024, to identify articles on the associations of any candidate variables with thyroid function test abnormalities, thyroid antibody positivity, or results of continuous thyroid function tests in pregnancy. Additional records were identified through citation searching. Study quality was assessed using the Newcastle-Ottawa Scale. We summarized the results using a narrative synthesis. Results: A total of 81 articles were included, describing 36 candidate variables. Thyroid antibody positivity was associated with a higher risk of overt or subclinical hypothyroidism compared with antibody negativity (absolute risks: 2.4-7.0% vs. 0.1-0.2% for overt hypothyroidism and 1.9-29.0% vs. 2.0-5.7% for subclinical hypothyroidism). In cases of iodine deficiency, sufficiency, and intake above pregnancy requirements or excess, the absolute risks for subclinical hypothyroidism were 2.2-42.6%, 1.42-16.0%, and 3.8-24.3%, respectively. A limited number of studies were available for history of autoimmune diseases, family history of thyroid disease, symptoms of hypothyroidism, and history of pregnancy loss, preterm delivery, or infertility. There was little or no association of current risk factors with isolated hypothyroxinemia or (subclinical) hyperthyroidism. We did not identify novel risk factors for thyroid function test abnormalities. Conclusions: Evidence for most currently recommended risk factors remains limited and heterogeneous, and no novel risk factor was identified. While risk factors can help guide thyroid function testing in pregnancy, a clinical risk assessment cannot be replaced. Future studies are needed to detect novel risk factors that can improve the accuracy and efficiency of identifying pregnant women at high risk of thyroid function test abnormalities, in particular, overt hypothyroidism.
引用
- Liu Y, Osinga JAJ, Maraka S, et al. Risk Factors for Thyroid Function Test Abnormalities During Pregnancy: A Systematic Review of the Literature to Validate Current Risk Factors and Identify Novel Ones. Thyroid. 2025. PMID: 40296843. doi:10.1089/thy.2024.0743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。